Kilroy Realty’s latest quarterly filing for Q1 2026 signals a notable decline in capitalized interest from prior year levels, suggesting a moderation or improved efficiency in its ongoing development projects. Concurrently, the company’s prepaid expenses and deferred financing costs contracted modestly, reflecting timing adjustments in project spend and steady amortization of financing fees. Kilroy’s business model is anchored in premier office and life science assets across high-barrier U.S. innovation hubs, with growth driven by a robust nine-site development pipeline and sustainability excellence that enhances tenant retention. The concentrated portfolio benefits from regional supply barriers but remains vulnerable to execution risk and regulatory exposures specific to California, Seattle, and Austin markets. Looking ahead, refinancing the $200 million term loan maturing in October 2026 will be a key liquidity milestone alongside leasing velocity and pipeline execution metrics.